Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safety and Efficacy of Voriconazole as Prophylactic Antifungal Therapy for Lung Transplant Recipients

NCT00455364 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00455364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00455364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safety and Efficacy of Voriconazole as Prophylactic Antifungal Therapy for Lung Transplant Recipients
Lead sponsor
University of Chicago
Phase
Phase 4
Overall status
Terminated
Start date
April 30, 2007
Completion date
April 30, 2007
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infection